Status:
COMPLETED
Ultrasound Detection of Peripheral IV Infiltration
Lead Sponsor:
ivWatch, LLC
Conditions:
Infiltration
IV Infiltration
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether commercial ultrasound imaging systems can discern normal from infiltrated tissue near a peripheral intravenous site.
Detailed Description
Peripheral intravenous (PIV) therapy is one of the most common invasive procedures performed in US hospitals. A majority of hospital patients require intravenous therapy each year in the United States...
Eligibility Criteria
Inclusion
- 18 years or older
- signed consent
- health form approved by professional practitioner
Exclusion
- abnormal bleeding or hemophilia
- absence of sensation in arms
- anemia
- cardiopulmonary disorders
- clotting disorders
- dehydration
- dizziness or fainting
- hepatitis
- high blood pressure (\>160 systolic or \> 115 diastolic)
- HIV / AIDS
- immune deficiency disorders
- known history of difficult venous access
- lymphedema
- major surgery or scar tissue which would complicate venous access
- recent radiation or chemotherapy
- received IV therapy in past 30 days
- history of seizures
- history of strokes
- sick or had infection in past 30 days
- high temperature (\>99.6F)
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01800552
Start Date
February 1 2013
End Date
February 1 2013
Last Update
February 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ivWatch,LLC
Williamsburg, Virginia, United States, 23185